Top Page
British American Tobacco
(LSE:BATS)
British American Tobacco (BATS) vs. iShares MSCI United Kingdom ETF (EWC)
British American Tobacco Business Overview & Revenue Model
British American Tobacco Earnings Call Summary
British American Tobacco Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.60B | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B |
| Gross Profit | 16.58B | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B |
| EBITDA | 4.85B | 7.74B | 8.83B | 12.29B | 11.67B | 11.70B |
| Net Income | 3.04B | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
Balance Sheet | ||||||
| Total Assets | 110.23B | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B |
| Cash, Cash Equivalents and Short-Term Investments | 4.89B | 5.81B | 5.26B | 4.03B | 3.27B | 3.38B |
| Total Debt | 35.21B | 36.95B | 39.73B | 43.14B | 39.66B | 43.97B |
| Total Liabilities | 63.05B | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B |
| Stockholders Equity | 46.87B | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
Cash Flow | ||||||
| Free Cash Flow | 7.29B | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B |
| Operating Cash Flow | 7.76B | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B |
| Investing Cash Flow | 766.00M | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M |
| Financing Cash Flow | -9.70B | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
British American Tobacco Technical Analysis
British American Tobacco Risk Analysis
British American Tobacco Peers Comparison
British American Tobacco Corporate Events
British American Tobacco p.l.c. announced the purchase of 178,453 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company intends to cancel these shares, which will impact the total number of shares in issue and those held in treasury, potentially affecting shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 179,932 of its ordinary shares from Goldman Sachs International as part of its ongoing share buyback program. This move, authorized by shareholders, is intended to enhance shareholder value by reducing the number of shares in circulation, which may positively impact the company’s stock price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 179,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company plans to cancel these shares, which will adjust the total number of shares in issue and those held in treasury, potentially impacting shareholder interests and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a tender offer for its €1 billion Perpetual Subordinated Fixed-to-Reset Rate Non-Call 5.25 Year Securities. This move is part of the company’s strategy to manage its hybrid capital portfolio proactively. The offer allows security holders to sell their securities ahead of the upcoming redemption date, with the potential for priority allocation in new securities issuance. This initiative reflects the company’s intention to optimize its financial structure and could impact stakeholders by providing liquidity and investment opportunities.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 136,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The shares were purchased at prices ranging from 3,798.00p to 3,835.00p and will be cancelled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 175,000 of its ordinary shares from Goldman Sachs International. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value for remaining shareholders and strengthening the company’s financial position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 165,000 of its ordinary shares from Goldman Sachs International. This move, part of a previously announced buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,185,746,237 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 183,458 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The repurchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder interests and the company’s market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 184,091 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests. Following this purchase, the company will have 2,186,093,719 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 183,105 of its ordinary shares as part of its ongoing buyback program. This move, executed through Banco Santander, S.A., is intended to cancel the purchased shares, thereby reducing the total number of shares in circulation. The transaction reflects the company’s strategy to enhance shareholder value and manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the appointment of Matthew Wright as an independent Non-Executive Director, effective from November 1, 2025. Wright’s extensive experience in advising global organizations on talent management and transformation is expected to support BAT’s ongoing cultural transformation and growth initiatives, particularly as the company pursues its ambition to create a Smokeless World.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 182,594 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. This move, approved by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation. Following the cancellation of these shares, the company will have 2,186,460,572 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 182,132 of its ordinary shares from Banco Santander, S.A. The company plans to cancel these shares, reducing the total number of shares in circulation, which may influence shareholder interests and voting rights. This move is part of a broader strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a share buyback program, commencing on 16 October 2025 and concluding on 23 December 2025, in collaboration with Goldman Sachs International. The initiative aims to reduce the company’s share capital by repurchasing and canceling up to 220,451,469 shares, as authorized by shareholders at the 2025 AGM, adhering to specific regulatory frameworks and pricing conditions.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 182,086 of its ordinary shares from Banco Santander as part of its ongoing share buyback program. This transaction, which was conducted under the authority granted by shareholders, aims to cancel the purchased shares, thereby reducing the number of shares in circulation and potentially increasing shareholder value. Following this buyback, the company will have 2,186,823,998 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of 184,025 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, authorized by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which could impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 182,423 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company intends to cancel these shares, which will adjust its total number of shares in issue and those held in treasury. This move is likely to impact shareholder interests and aligns with regulatory transparency requirements.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase and cancellation of 182,160 of its ordinary shares as part of its ongoing share buyback program. This transaction, conducted with Banco Santander, S.A., is part of the company’s strategy to optimize its capital structure and deliver value to shareholders. Following this buyback, the company has 2,187,372,221 ordinary shares in issue, excluding treasury shares, which carry voting rights. This move is expected to impact the company’s share capital and may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executives, including the Chief Executive and Chief Marketing Officer, have purchased ordinary shares in the company through the Partnership Share Scheme, a HMRC approved Share Incentive Plan. This move reflects a commitment to align the interests of the company’s leadership with those of its shareholders, potentially impacting the company’s market perception and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 126,705 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, authorized by shareholders, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,187,554,381 ordinary shares in issue, excluding treasury shares, which could impact shareholders’ interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of 30 September 2025, which consists of over 2.18 billion ordinary shares with voting rights. This information is crucial for shareholders to determine their voting rights interest under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 126,462 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to cancel the acquired shares, reducing the total number of shares in circulation and potentially enhancing shareholder value. The buyback reflects the company’s strategic financial management and could impact stakeholders by altering shareholding percentages.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 126,658 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. This transaction, authorized by shareholders and aimed at reducing the number of shares in circulation, reflects the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 126,296 of its ordinary shares as part of its ongoing buyback program. This transaction, carried out with Banco Santander, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value. Following the cancellation of these shares, the company will have 2,187,933,243 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 126,177 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move is intended to reduce the number of shares in circulation, potentially increasing shareholder value and adjusting the company’s capital structure. Following the cancellation of these shares, the company will have 2,188,059,415 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 127,591 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, authorized by shareholders, aims to cancel the acquired shares, potentially impacting the company’s share value and voting rights structure, with implications for stakeholders in terms of shareholding notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 126,498 ordinary shares as part of its ongoing buyback program. The shares were acquired from Banco Santander, S.A. and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value. The transaction may impact shareholder voting rights and requires stakeholders to assess their holdings under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 124,038 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, which follows shareholder approval, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation and potentially increasing the value of remaining shares. This strategic financial maneuver could strengthen the company’s market position and provide value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the buyback of 122,059 of its ordinary shares from Banco Santander as part of a previously announced buyback program. This move is part of the company’s strategy to manage its capital structure and return value to shareholders. The purchased shares will be canceled, reducing the total number of shares in circulation, which could impact shareholder value and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the finalization details for its November 2025 dividend payment, part of the interim dividend declared earlier in February 2025. Shareholders on the South Africa branch register will receive their dividends in rand, with the exchange rate set at £:R=23.5111. The dividend, regarded as a ‘foreign dividend’ for South Africa Dividends Tax purposes, will be subject to a 20% tax unless exemptions apply. The announcement maintains the previously declared dividend schedule and provides clarity on the tax implications for South African shareholders.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the pricing of a $750 million notes offering by its subsidiary, B.A.T Capital Corporation. The notes, due in 2033, will be used for general corporate purposes, including potential debt repayment. The issuance is expected to close on September 22, 2025, with several financial institutions acting as joint book-running managers. This move is part of BAT’s broader financial strategy and reflects its ongoing efforts to manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a buyback of 121,708 ordinary shares as part of its ongoing share repurchase program. This transaction, conducted with Banco Santander, S.A., is in line with the authority granted by shareholders and aims to cancel the purchased shares, potentially impacting the company’s share capital structure and shareholder interests.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 121,559 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move is intended to cancel the purchased shares, which will reduce the total number of shares in circulation, potentially impacting shareholder value and market perception.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 122,000 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through Banco Santander, S.A., reflects the company’s strategic move to manage its share capital and potentially enhance shareholder value. Following the cancellation of these shares, the company will have 2,188,927,859 ordinary shares in issue, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 120,384 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 119,599 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will result in a total of 2,189,168,191 ordinary shares in issue, excluding treasury shares. This move is part of the company’s strategy to manage its capital structure and could impact shareholder interests, as it may influence voting rights and share value.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 119,599 of its ordinary shares from Banco Santander as part of its buyback program. This transaction, conducted under the authority granted by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder interests and market perception.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco (BAT) has announced changes to its Management Board, with Jerome Abelman stepping down as General Counsel after 23 years with the company. Paul McCrory will succeed him, bringing nearly two decades of experience within BAT. These changes reflect BAT’s commitment to maintaining strong legal leadership aligned with its strategic priorities. The company continues to focus on its goal of achieving sustainable growth and enhancing its regulatory affairs and communications agenda.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 119,925 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, conducted under the authority granted by shareholders, is part of the company’s strategy to enhance shareholder value. Following this purchase, the company plans to cancel the shares, thereby reducing the number of shares in circulation and potentially increasing the value of remaining shares. This move is expected to impact the company’s market positioning by demonstrating financial strength and commitment to returning value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 120,208 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, reducing the total number of shares in circulation. This move is part of a broader strategy to enhance shareholder value and manage the company’s capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 120,403 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move is in line with the authority granted by shareholders and aims to cancel the purchased shares, thereby reducing the number of shares in circulation. The transaction could potentially impact shareholder value and market dynamics by altering the company’s share structure and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 120,970 of its ordinary shares from Banco Santander as per the authority granted by shareholders. This move is part of a broader strategy to manage its capital structure and enhance shareholder value, potentially impacting the company’s market positioning by reducing the number of shares in circulation and increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £3400.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executives, including the Chief Executive and other directors, have purchased ordinary shares in the company through the Partnership Share Scheme, a HMRC approved Share Incentive Plan. This move, conducted on the London Stock Exchange, reflects a strategic alignment of the company’s leadership with its shareholders and may indicate confidence in the company’s future performance.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £3400.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the repurchase of 122,300 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with Banco Santander, is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share and improving market positioning.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £3400.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 122,244 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, conducted under the authority granted at the company’s Annual General Meeting, reflects the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £3400.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 119,900 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The company plans to cancel these shares, which will reduce the total number of shares in issue to 2,190,130,716, excluding treasury shares. This move is part of the company’s strategy to manage its capital structure and could impact shareholder interests by potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £3400.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of August 29, 2025, which consists of over 2.19 billion ordinary shares with voting rights. The company also holds approximately 133 million shares in treasury. This information is crucial for shareholders to calculate their voting rights interests in accordance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4467.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 119,122 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will result in a total of 2,190,250,088 ordinary shares in issue. This move is part of a strategy to manage the company’s capital structure and may have implications for shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4467.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 122,841 ordinary shares from Banco Santander as part of its ongoing buyback program. This move is part of the company’s strategy to manage its capital structure, potentially impacting shareholder value and market perception by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 120,989 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, which took place on August 27, 2025, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 120,940 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The company plans to cancel these shares, which will result in a reduced number of shares in issue, potentially impacting shareholder interests and voting rights. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 117,040 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will result in 2,190,729,038 ordinary shares in issue. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco (BAT) announced a significant change in its leadership team with the stepping down of Soraya Benchikh as Chief Financial Officer. Javed Iqbal will serve as the interim CFO while the company seeks a permanent successor. This transition comes as BAT continues to perform ahead of expectations and remains on track to meet its full-year guidance. The company is committed to its strategic goals, including the profitable transformation towards smokeless products and sustainability, which are crucial for its future growth and industry positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 118,007 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, carried out under the authority granted at the company’s Annual General Meeting, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,190,845,579 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 103,500 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will adjust the total number of shares in issue and those held in treasury. This move is part of BAT’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 127,690 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move is intended to enhance shareholder value by reducing the number of shares in circulation, thus potentially increasing earnings per share. The cancellation of these shares will adjust the total number of shares in issue and those held in treasury, impacting shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 131,650 of its ordinary shares from Banco Santander as part of its ongoing buyback programme. The shares were bought at a volume-weighted average price of 4,177.0572 pence and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and could potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the acquisition of shares by Serpil Timuray, a Non-Executive Director, and Abdurrahman Murat Timuray, a person closely associated with her. The transaction involved the reinvestment of dividend income to acquire ordinary shares, highlighting the company’s ongoing commitment to shareholder value and engagement with its leadership.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 113,687 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The company intends to cancel these shares, which will reduce the total number of shares in issue, potentially impacting shareholder voting rights and interests. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced a transaction involving its Chief Executive, Tadeu Marroco, and Luciana Franco Do Amaral, who jointly acquired ordinary shares through the reinvestment of dividend income. This transaction, conducted on the London Stock Exchange, reflects the company’s ongoing commitment to aligning executive interests with shareholder value, potentially impacting stakeholder confidence and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 118,433 ordinary shares from Banco Santander as part of its ongoing buyback program. This move, which involves the cancellation of the purchased shares, is likely to impact the company’s share capital structure and could influence shareholder value and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 115,944 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving Javed Iqbal, Director of Digital and Information, who has sold 2,500 ordinary shares at £42.22292 each, totaling £105,557.30. This transaction, conducted on the London Stock Exchange, reflects ongoing managerial activities within the company, potentially impacting shareholder perceptions and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of 116,582 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, approved by shareholders, aims to cancel the acquired shares, thereby reducing the number of shares in circulation and potentially enhancing shareholder value. The transaction reflects the company’s strategic efforts to manage its capital structure and maintain its market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 118,139 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. This move, authorized by shareholders in April 2025, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may influence shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 119,100 ordinary shares from Banco Santander as part of its ongoing strategy to enhance shareholder value. The company plans to cancel these shares, which will reduce the total number of shares in issue, potentially impacting shareholder voting rights and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced that several of its executive directors and other key personnel have purchased ordinary shares in the company through the Partnership Share Scheme, an HMRC-approved Share Incentive Plan. This move, involving key figures such as the Chief Executive and Chief Financial Officer, reflects a commitment to align management interests with shareholder value, potentially strengthening investor confidence and signaling positive internal sentiment about the company’s future prospects.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 112,660 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The company intends to cancel these shares, which will adjust the number of shares in issue and those held in treasury. This move is part of the company’s strategy to manage its capital structure and could impact shareholder interests by potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 112,660 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The shares, purchased at an average price of 4,216.4370 pence, will be canceled, reducing the total number of shares in circulation. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its stock market performance and investor relations.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 113,078 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback programme. The company plans to cancel these shares, which will reduce the total number of shares in issue to 2,192,139,587. This move is part of a strategic effort to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executive directors and senior management have acquired ordinary shares in the company through the reinvestment of dividend income. This transaction, conducted on the London Stock Exchange, reflects the ongoing commitment of the company’s leadership to align their interests with those of shareholders, potentially impacting the company’s market perception and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its senior executives, including regional directors and the Chief Marketing Officer, have acquired ordinary shares in the company through the reinvestment of dividend income. These transactions, conducted on the London Stock Exchange, reflect the company’s ongoing commitment to aligning management interests with shareholder value. The acquisitions may enhance stakeholder confidence in the company’s financial strategies and market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced transactions involving its Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, who acquired quarterly dividend equivalent shares under the company’s Deferred Share Bonus Scheme. These transactions reflect the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced a transaction involving Holly Keller Koeppel, a Non-Executive Director, who received additional Deferred Stock Units (DSUs) linked to the company’s American Depositary Shares (ADSs). This transaction, which reflects the value of dividends declared on the underlying ADSs, highlights the company’s ongoing commitment to aligning executive compensation with shareholder interests, potentially impacting investor confidence and stakeholder engagement.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the approval and publication of a Supplementary Prospectus related to its £25 billion Euro Medium Term Note Programme. This development is significant as it reflects the company’s ongoing efforts to manage its financial strategies and maintain its market position, potentially impacting stakeholders by providing additional financial instruments for investment.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 114,500 of its ordinary shares as part of its ongoing buyback program. This move, facilitated by Banco Santander, is aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. The company plans to cancel the purchased shares, which will result in 2,192,251,968 ordinary shares remaining in issue. This strategic financial maneuver is part of BAT’s efforts to optimize its capital structure and deliver value to its shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 114,176 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its share capital and voting rights as of July 31, 2025. The company reported an issued share capital of 2,192,753,745 ordinary shares, with 133,003,645 shares held in treasury. This information is crucial for shareholders to determine their voting rights interests in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 123,745 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will impact the total number of shares in issue and may affect shareholder notifications under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £36.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a new phase in its share buyback programme, commencing on 31 July 2025 and concluding on 15 October 2025, in collaboration with Banco Santander. This initiative aims to reduce the company’s share capital by repurchasing and cancelling up to 220,451,469 shares, as authorized by its shareholders at the 2025 AGM. The buyback is structured to comply with regulatory requirements, ensuring the maximum price paid for shares adheres to specific financial guidelines. This move is expected to impact the company’s financial structure and shareholder value positively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 150,365 ordinary shares as part of its ongoing share repurchase program. This move, in line with shareholder approval, aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco’s half-year report for 2025 shows a slight decline in revenue due to currency headwinds, but an increase at constant exchange rates driven by growth in the U.S. and the success of Velo Plus. The company’s New Categories segment, which includes smokeless products, now accounts for 18.2% of total revenue, with a significant increase in contribution margin. Despite challenges in regions like APMEA, BAT remains on track to meet its full-year guidance, with plans for continued innovation and investment in high-profit areas, enhancing shareholder value through strong cash returns and share buy-backs.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £2800.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 139,813 ordinary shares as part of its ongoing share repurchase program. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 153,454 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through UBS AG London Branch, is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. The cancellation of these shares will adjust the total number of shares in issue, impacting shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback, purchasing 148,792 of its ordinary shares from UBS AG London Branch as part of its ongoing buyback program. The company plans to cancel these shares, which will impact the total number of shares in issue, potentially affecting shareholder interests and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 129,938 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, authorized by shareholders, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the repurchase of 129,938 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through UBS AG London Branch, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.